News

news-preview-placeholder
Ohio Enacts Limits on Opioid Prescriptions

Starting August 31, 2017, Ohio joins other states that have enacted limits when prescribing opioids…

Aug 25, 2017
news-preview-placeholder
Excellence in Caring: Bryan

Kudos goes to Bryan for handling a late evening issue to ensure our NARS claimant…

Aug 15, 2017
news-preview-placeholder
Kentucky Law Restricts Opioid Prescribing

Kentucky is following several other states that have recently enacted new laws to restrict opioid…

Aug 14, 2017
news-preview-placeholder
DEA Proposes Reduction in Manufacturing of Opioids for 2018

The DEA has proposed to reduce the manufacturing of controlled substances in the United States…

Aug 07, 2017
news-preview-placeholder
ASIA Summer Conference

Tami Bell, Account Executive, will be at booth #25 in Destin for the ASIA Summer…

Aug 06, 2017
news-preview-placeholder
Launch of Generic Relpax

The generic equivalent of Relpax (Eletriptan) has just been released, following FDA approval. Relpax is…

Jul 25, 2017
news-preview-placeholder
Louisiana Enacts New Laws Regarding Opioid Prescribing Limits

Louisiana joined several states in enacting new laws limiting the days’ supply of a new…

Jul 17, 2017
news-preview-placeholder
2017 LASIE Open Forum

John Means, Regional Sales Manager, will be attending the 2017 LASIE Open Forum. He will…

Jul 12, 2017
news-preview-placeholder
Excellence in Caring: Lauren

Lauren has been with the Retail Department at Carlisle Medical for nearly eight months. She…

news-preview-placeholder
Endo Pharmaceuticals, Inc. Announces Withdrawal of Opana ER

Endo Pharmaceuticals announced it would be voluntarily withdrawing Opana ER (Oxymorphone ER) from the market….

Jul 10, 2017